Perceived utility and feasibility of pathogen genomics for public health practice: a survey among public health professionals working in the field of infectious diseases, Belgium, 2019.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
31 Aug 2020
Historique:
received: 04 12 2019
accepted: 23 08 2020
entrez: 2 9 2020
pubmed: 2 9 2020
medline: 14 1 2021
Statut: epublish

Résumé

Pathogen genomics is increasingly being translated from the research setting into the activities of public health professionals operating at different levels. This survey aims to appraise the literacy level and gather the opinions of public health experts and allied professionals working in the field of infectious diseases in Belgium concerning the implementation of next-generation sequencing (NGS) in public health practice. In May 2019, Belgian public health and healthcare professionals were invited to complete an online survey containing eight main topics including background questions, general attitude towards pathogen genomics for public health practice and main concerns, genomic literacy, current and planned NGS activities, place of NGS in diagnostic microbiology pathways, data sharing obstacles, end-user requirements, and key drivers for the implementation of NGS. Descriptive statistics were used to report on the frequency distribution of multiple choice responses whereas thematic analysis was used to analyze free text responses. A multivariable logistic regression model was constructed to identify important predictors for a positive attitude towards the implementation of pathogen genomics in public health practice. 146 out of the 753 invited public health professionals completed the survey. 63% of respondents indicated that public health agencies should be using genomics to understand and control infectious diseases. Having a high level of expertise in the field of pathogen genomics was the strongest predictor of a positive attitude (OR = 4.04, 95% CI = 1.11 - 17.23). A significantly higher proportion of data providers indicated to have followed training in the field of pathogen genomics compared to data end-users (p < 0.001). Overall, 79% of participants expressed interest in receiving further training. Main concerns were related to the cost of sequencing technologies, data sharing, data integration, interdisciplinary working, and bioinformatics expertise. Belgian health professionals expressed favorable views about implementation of pathogen genomics in their work activities related to infectious disease surveillance and control. They expressed the need for suitable training initiatives to strengthen their competences in the field. Their perception of the utility and feasibility of pathogen genomics for public health purposes will be a key driver for its further implementation.

Sections du résumé

BACKGROUND BACKGROUND
Pathogen genomics is increasingly being translated from the research setting into the activities of public health professionals operating at different levels. This survey aims to appraise the literacy level and gather the opinions of public health experts and allied professionals working in the field of infectious diseases in Belgium concerning the implementation of next-generation sequencing (NGS) in public health practice.
METHODS METHODS
In May 2019, Belgian public health and healthcare professionals were invited to complete an online survey containing eight main topics including background questions, general attitude towards pathogen genomics for public health practice and main concerns, genomic literacy, current and planned NGS activities, place of NGS in diagnostic microbiology pathways, data sharing obstacles, end-user requirements, and key drivers for the implementation of NGS. Descriptive statistics were used to report on the frequency distribution of multiple choice responses whereas thematic analysis was used to analyze free text responses. A multivariable logistic regression model was constructed to identify important predictors for a positive attitude towards the implementation of pathogen genomics in public health practice.
RESULTS RESULTS
146 out of the 753 invited public health professionals completed the survey. 63% of respondents indicated that public health agencies should be using genomics to understand and control infectious diseases. Having a high level of expertise in the field of pathogen genomics was the strongest predictor of a positive attitude (OR = 4.04, 95% CI = 1.11 - 17.23). A significantly higher proportion of data providers indicated to have followed training in the field of pathogen genomics compared to data end-users (p < 0.001). Overall, 79% of participants expressed interest in receiving further training. Main concerns were related to the cost of sequencing technologies, data sharing, data integration, interdisciplinary working, and bioinformatics expertise.
CONCLUSIONS CONCLUSIONS
Belgian health professionals expressed favorable views about implementation of pathogen genomics in their work activities related to infectious disease surveillance and control. They expressed the need for suitable training initiatives to strengthen their competences in the field. Their perception of the utility and feasibility of pathogen genomics for public health purposes will be a key driver for its further implementation.

Identifiants

pubmed: 32867727
doi: 10.1186/s12889-020-09428-4
pii: 10.1186/s12889-020-09428-4
pmc: PMC7456758
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1318

Références

PLoS Pathog. 2012;8(8):e1002824
pubmed: 22876174
Lancet Infect Dis. 2015 Dec;15(12):1420-8
pubmed: 26515523
F1000Res. 2018 Mar 27;7:401
pubmed: 29636909
Am J Infect Control. 2017 Feb 1;45(2):170-179
pubmed: 28159067
Nat Rev Genet. 2012 Sep;13(9):601-612
pubmed: 22868263
Int J Antimicrob Agents. 2015 May;45(5):477-84
pubmed: 25769787
Expert Rev Mol Diagn. 2015;15(12):1517-9
pubmed: 26548640
PLoS One. 2015 Jun 26;10(6):e0131166
pubmed: 26115441
Implement Sci. 2019 Aug 13;14(1):79
pubmed: 31409417
PLoS One. 2018 May 2;13(5):e0195885
pubmed: 29718947
Trends Microbiol. 2016 Apr;24(4):241-245
pubmed: 26875619
J Infect Dis. 2015 Jul 15;212(2):294-301
pubmed: 25489002
Foodborne Pathog Dis. 2018 Mar;15(3):161-167
pubmed: 29336594
BMC Infect Dis. 2015 Apr 03;15:174
pubmed: 25887164
Clin Microbiol Infect. 2018 Apr;24(4):355-360
pubmed: 29117578
Infect Control Hosp Epidemiol. 2015 Sep;36(9):1058-64
pubmed: 26050101
Lancet Respir Med. 2016 Jan;4(1):49-58
pubmed: 26669893
Hum Resour Health. 2017 Jun 27;15(1):42
pubmed: 28655303
Euro Surveill. 2015 Apr 23;20(16):
pubmed: 25953273
Clin Microbiol Infect. 2018 Apr;24(4):335-341
pubmed: 29074157
PeerJ. 2018 Jan 10;6:e4218
pubmed: 29340235
Trends Microbiol. 2018 Dec;26(12):1035-1048
pubmed: 30193960
Genome Biol. 2015 May 30;16:114
pubmed: 26025440
J Clin Microbiol. 2015 Nov;53(11):3565-73
pubmed: 26354815
Front Med. 2018 Feb;12(1):23-33
pubmed: 29318441
BMC Health Serv Res. 2014 May 28;14:239
pubmed: 24885316
Expert Rev Mol Diagn. 2016 Jun;16(6):619-21
pubmed: 26953799
J Antimicrob Chemother. 2015 Dec;70(12):3191-9
pubmed: 26316381
Front Public Health. 2017 Dec 18;5:347
pubmed: 29326921
Emerg Infect Dis. 2012 Nov;18(11):e1
pubmed: 23092707
Public Health Rep. 2017 Mar/Apr;132(2):241-250
pubmed: 28141970
Emerg Infect Dis. 2017 Nov;23(11):1784-1791
pubmed: 29047425
Zoonoses Public Health. 2016 Aug;63(5):351-7
pubmed: 26537766
Nat Rev Genet. 2009 May;10(5):331-5
pubmed: 19308065
R Soc Open Sci. 2017 Mar 29;4(3):160721
pubmed: 28405360
Front Microbiol. 2018 Mar 20;9:511
pubmed: 29616014
Genet Med. 2007 Aug;9(8):496-503
pubmed: 17700387
J Clin Microbiol. 2017 Mar;55(3):703-714
pubmed: 28031438
Euro Surveill. 2013 Jan 24;18(4):20386
pubmed: 23369387
Clin Microbiol Infect. 2016 Jul;22(7):620-4
pubmed: 27145209
Am J Public Health. 2008 Sep;98(9):1651-7
pubmed: 18633090
MMWR Morb Mortal Wkly Rep. 2017 Jun 30;66(25):663-667
pubmed: 28662015
PLoS Negl Trop Dis. 2017 Jan 6;11(1):e0005274
pubmed: 28060810
JAMA. 2019 Mar 5;321(9):893-894
pubmed: 30763433
Pathology. 2015 Apr;47(3):199-210
pubmed: 25730631
Trop Med Infect Dis. 2019 May 31;4(2):
pubmed: 31159338
Zoonoses Public Health. 2018 Feb;65(1):e229-e236
pubmed: 29226606
J Infect Dev Ctries. 2013 Mar 14;7(3):182-90
pubmed: 23492995
Euro Surveill. 2017 Dec;22(49):
pubmed: 29233257
J Clin Microbiol. 2018 Oct 25;56(11):
pubmed: 30135232

Auteurs

N Van Goethem (N)

Scientific Directorate of Epidemiology and public health, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium. Nina.VanGoethem@sciensano.be.
Department of Epidemiology and Biostatistics, Institut de recherche expérimentale et clinique, Faculty of Public Health, Université catholique de Louvain, Clos Chapelle-aux-champs 30, 1200, Woluwe-Saint-Lambert, Belgium. Nina.VanGoethem@sciensano.be.

M J Struelens (MJ)

Surveillance Section, European Centre for Disease Prevention and Control, Gustav den III:s Boulevard, 169 73 Solna, Stockholm, Sweden.
Faculté de Médecine, Université libre de Bruxelles, 808 route de Lennik, 1070, Brussels, Belgium.

S C J De Keersmaecker (SCJ)

Transversal activities in Applied Genomics, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.

N H C Roosens (NHC)

Transversal activities in Applied Genomics, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.

A Robert (A)

Department of Epidemiology and Biostatistics, Institut de recherche expérimentale et clinique, Faculty of Public Health, Université catholique de Louvain, Clos Chapelle-aux-champs 30, 1200, Woluwe-Saint-Lambert, Belgium.

S Quoilin (S)

Scientific Directorate of Epidemiology and public health, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.

H Van Oyen (H)

Scientific Directorate of Epidemiology and public health, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
Department of Public Health and Primary Care, Faculty of Medicine, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.

B Devleesschauwer (B)

Scientific Directorate of Epidemiology and public health, Sciensano, J. Wytsmanstraat 14, 1050, Brussels, Belgium.
Department of Veterinary Public Health and Food Safety, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820, Merelbeke, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH